the success of this approach suggests that , if their safety could be established , similar `` '' curative '' '' strategies might be developed for the treatment of patients with severe antibody-mediated autoimmune disorders , such as myasthenia gravis .
C0004364
d autoimmune disorde
C0026896
myasthenia grav